Human(HIV)
Immunodeficiency
_ Pathophysiology,
Virus
Human
Transmission
(HIV)
Immunodeficiency
_ Pathophysiology,
& Nursing Virus
CareTransmission
Review.pdf
(HIV) _ Pathophysiology,
& Nursing CareTransmission
Review.pdf & Nursing Care Review.pdf
Human
Immunodeficiency
Virus (HIV) |
Pathophysiology,
Transmission &
Nursing Care
Review
Human Immunodeficiency Virus
Human(HIV)
Immunodeficiency
_ Pathophysiology,
Virus
Human
Transmission
(HIV)
Immunodeficiency
_ Pathophysiology,
& Nursing Virus
CareTransmission
Review.pdf
(HIV) _ Pathophysiology,
& Nursing CareTransmission
Review.pdf & Nursing Care Review.pdf
,Human Immunodeficiency virus.pdf Human Immunodeficiency virus.pdf Human Immunodeficiency virus.pdf
• 1981: First Clinical Cases Reported
• 1986: Virus Isolated
• 1987: First HIV Drug Pre-Approved by the FDA
• 1997: Highly Active Antiretroviral Therapy
• 2012: First Drug for Pre-Exposure Prophylaxis
EPIDEMIOLOGY: GLOBALLY 40.8 million
how many people are infected
EPIDEMIOLOGY: GLOBALLY 0.7%
what is the prevalence rate among adults aged 15-49
EPIDEMIOLOGY: GLOBALLY 50%
how many infected persons are female
Human Immunodeficiency virus.pdf Human Immunodeficiency virus.pdf Human Immunodeficiency virus.pdf
, Human Immunodeficiency virus.pdf Human Immunodeficiency virus.pdf Human Immunodeficiency virus.pdf
EPIDEMIOLOGY: GLOBALLY Sub-Saharan Africa
where is the highest burden of new infections
EPIDEMIOLOGY: GLOBALLY Heterosexual Contact
75% of Infections are from
EPIDEMIOLOGY: GLOBALLY Vertical Transmission
95% of Childhood Cases are from
EPIDEMIOLOGY: NATIONALLY 1.2 million
how may people are infected
EPIDEMIOLOGY: NATIONALLY 31%
how many infected persons are female
Human Immunodeficiency virus.pdf Human Immunodeficiency virus.pdf Human Immunodeficiency virus.pdf